Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer


Boyraz B., Sendur M. A. N., AKSOY S., BABACAN T., Roach E. C., KIZILARSLANOĞLU M. C., ...More

CURRENT MEDICAL RESEARCH AND OPINION, vol.29, no.4, pp.405-414, 2013 (SCI-Expanded) identifier identifier identifier

Abstract

Background: